VCO Trial

A Double-blind Randomized Trial on the Effectiveness of Syferol - IHP® (A Special Blend of Virgin Coconut Oil and Cold-Pressed Ocimum sanctum Oil) for the Treatment of Peptic Ulcer Disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201606001665364

Enrollment

Registered

2016-06-06

Start date

2016-10-03

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System Peptic Ulcer disease

Interventions

SYFEROL IHP®

Triple therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Both male and female individuals aged between 18-60 years. Patients with confirmed diagnosis of peptic ulcer disease. Patients with normal liver function tests, renal function tests and hematological profiles will be included.

Exclusion criteria

Exclusion criteria: Patients refusal of consent to the study Pregnancy. Patients falling outside the age bracket of 18-60 years.

Design outcomes

Primary

Measure	Time frame
number of patients with negative urea breath test and/or healing of ulcer at endoscopy	—

Secondary

Measure	Time frame
presence of adverse events (such as diarrhea, nausea, vomiting and colitis);abnormal renal function (serum electrolyte, urea and creatinine);abnormal liver function tests ;abnormal hematological profile parameters	—

Countries

Nigeria

Contacts

Public ContactCharles Esimone

Prof Dept Pharmaceutical Microbiol, Biotechnol, Nnamdi Azikiwe Univ, Awka, Nigeria

co.esimone@unizik.edu.ng+2348062835781

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 22, 2026